Anti-Amyloid Fibril antibody [mOC22] - BSA and Azide free (ab251426)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [mOC22] to Amyloid Fibril - BSA and Azide free
- Suitable for: Dot blot, IHC-P
- Reacts with: Human
Overview
-
Product name
Anti-Amyloid Fibril antibody [mOC22] - BSA and Azide free
See all Amyloid Fibril primary antibodies -
Description
Rabbit monoclonal [mOC22] to Amyloid Fibril - BSA and Azide free -
Host species
Rabbit -
Tested applications
Suitable for: Dot blot, IHC-Pmore details -
Species reactivity
Reacts with: Human -
Immunogen
Other Immunogen Type corresponding to Human Amyloid Fibril. (Amyloid beta 1-42 fibrils).
Database link: P05067 -
General notes
ab251426 is the carrier-free version of ab205339 This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.
Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with
Ab251426 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.
Maxpar® is a trademark of Fluidigm Canada Inc.
This antibody was developed as part of a collaboration between Abcam and Professor Charles Glabe, UC Irvine.
ab251426 (mOC22) recognizes a conformation-dependent and aggregation-specific generic fibril epitope that is independent of the peptide sequence. Although it maps to a linear segment of Aß (residues 3-7, EFRHD) it also reacts with alpha synuclein and islet amyloid polypeptide (IAPP) fibrils but not monomers (Hatami et al 2014). mOC22 preferentially stains the central core of cored plaques. mOC22 also stains misfolded or aggregated intraneuronal amyloid deposits (Hatami et. al 2014). Immunoreactivity on western blots is enhanced by boiling the membrane.
For further information on the immunogen, please refer to Hatami et al. 2014 and Kayed et al. 2007.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. Do Not Freeze. -
Storage buffer
pH: 7.2
Constituent: PBS -
Carrier free
Yes -
Concentration information loading...
-
Clonality
Monoclonal -
Clone number
mOC22 -
Isotype
IgG -
Research areas
Images
-
This data was developed using ab205339, the same antibody clone in a different buffer formulation.IHC image of Amyloid Fibril staining in Human Brain Alzheimer formalin fixed paraffin embedded tissue section*, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab205339, 0.1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times. *Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
-
This data was developed using ab205339, the same antibody clone in a different buffer formulation.Dot blot analysis of beta Amyloid labeled with ab205339 at 1/7000 dilution. Lane 1: beta Amyloid (Aβ) 1-40; Lane 2: beta Amyloid (Aβ) 1-42. Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/30000 was used as secondary antibody. Blocking/Dilution buffer: 5% NFDM/TBST. Exposure time: 30 seconds. Note: Antibody reactivity was assessed using a dot blot, which is a non-quantitative method that maintains the native conformation of beta Amyloid. beta Amyloid 1-40 and 1-42 peptides underwent the following aggregation conditions before being spotted onto a nitrocellulose membrane and detected using ab205339: Monomers: 0.3 mg of beta Amyloid peptide was dissolved in 30 µl 100 mM NaOH and incubated at room temperature for 10 minutes. It was then diluted with 970 µl of 1% SDS and boiled for five minutes. Oligomers: 0.3 mg of beta Amyloid peptide was dissolved in 30 µl 100 mM NaOH and incubated at room temperature for 10 minutes. It was then diluted with 970 µl of 10 mM phosphate buffer pH 7.4 containing 0.02% sodium azide and incubated at room temperature for four days. Fibrils: 0.3 mg of beta Amyloid peptide was dissolved in 1 ml 50% hexafluoroisopropanol (HFIP) with 0.02% sodium azide. It was then stirred constantly for nine days; the first seven with a cap on and the final two with the cap removed to allow evaporation of the HFIP. Fibrils were then sedimented at 20,000 rpm in a microcentrifuge for 20 minutes and resuspended in 1 ml of PBS + 0.02% sodium azide.
-
This data was developed using ab205339, the same antibody clone in a different buffer formulation.Negative control (secondary ab only) Dot blot analysis of beta Amyloid. Lane 1: beta Amyloid (Aβ) 1-40; Lane 2: beta Amyloid (Aβ) 1-42. Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/30000 was used as secondary antibody. Blocking/Dilution buffer: 5% NFDM/TBST. Exposure time: 30 seconds.
-